Related Experiment Video
Updated: Jul 14, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Bullous Type 2 Lepra Reaction: A Rare and Significant Case Report
Hrithik Dakssesh Putta Nagarajan1, Balakrishnan Kamaraj2, Keerthivasan Selvanathan1
1Department of Internal Medicine Madurai Medical College Madurai Tamil Nadu India.
Bullous type 2 lepra reactions, a rare leprosy presentation, cause blistering. Early diagnosis and treatment are crucial for better patient outcomes.
Area of Science:
- Dermatology
- Infectious Diseases
- Immunology
Background:
- Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
- Lepra reactions are immune-mediated inflammatory episodes occurring in leprosy patients.
- Bullous type 2 lepra reactions are an uncommon but severe manifestation.
Purpose of the Study:
- To highlight the rare initial presentation of bullous type 2 lepra reactions.
- To emphasize the importance of differentiating these reactions from other bullous disorders.
- To underscore the need for prompt therapeutic intervention.
Main Methods:
- Literature review of bullous type 2 lepra reactions.
- Clinical case analysis (if applicable).
- Differential diagnosis considerations for vesiculo-bullous lesions.
Main Results:
- Bullous type 2 lepra reactions present with characteristic vesiculo-bullous lesions.
- These reactions can be the initial manifestation of leprosy.
- Timely recognition is key to effective management.
Conclusions:
- Bullous type 2 lepra reactions require early identification to prevent complications.
- Distinguishing these reactions from other blistering diseases is critical.
- Prompt initiation of corticosteroids and multidrug therapy improves patient prognosis.
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Leishmaniasis
Hypersensitivity Reactions: Immune-Complex Reactions

